Conmed (CNMD) Cash from Financing Activities (2010 - 2026)
Conmed posted quarterly Cash from Financing Activities of -$22.6 million for Q1 2026, up 20.58% year-on-year from -$18.7 million in Q1 2025, and up 39.65% on a QoQ basis from -$37.4 million in Q4 2025.
Conmed (CNMD) has 17 years of Cash from Financing Activities data on file, last reported at -$22.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 20.58% year-over-year to -$22.6 million; the trailing twelve-month figure through Mar 2026 stood at -$130.0 million (up 19.96% YoY), and the FY2025 full-year result was -$135.8 million, up 10.05% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$22.6 million, up from -$37.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $159.1 million in Q2 2022 and bottomed at -$58.8 million in Q4 2023.
- The 5-year median for Cash from Financing Activities is -$26.5 million (2025), against an average of -$11.5 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities soared 820.17%; it then plunged 610.34% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at $11.5 million in 2022, then slumped by 610.34% to -$58.8 million in 2023, then gained by 13.1% to -$51.1 million in 2024, then grew by 26.83% to -$37.4 million in 2025, then soared by 39.65% to -$22.6 million in 2026.
- The last three Cash from Financing Activities figures came in at -$22.6 million (Q1 2026), -$37.4 million (Q4 2025), and -$43.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | -22.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.55 Mn |
| Mar 31, 2026 | -22.55 Mn |
| Dec 31, 2025 | -37.37 Mn |
| Dec 31, 2025 | -37.37 Mn |
| Sep 30, 2025 | -43.53 Mn |
| Sep 30, 2025 | -43.53 Mn |
| Jun 30, 2025 | -26.53 Mn |
| Jun 30, 2025 | -26.53 Mn |
| Mar 31, 2025 | -28.40 Mn |
| Mar 31, 2025 | -28.40 Mn |
| Dec 31, 2024 | -51.07 Mn |
| Dec 31, 2024 | -51.07 Mn |
| Sep 30, 2024 | -38.83 Mn |
| Sep 30, 2024 | -38.83 Mn |
| Jun 30, 2024 | -44.09 Mn |
| Jun 30, 2024 | -44.09 Mn |
| Mar 31, 2024 | -17.01 Mn |
| Mar 31, 2024 | -17.01 Mn |
| Dec 31, 2023 | -58.77 Mn |
| Dec 31, 2023 | -58.77 Mn |
| Sep 30, 2023 | -37.23 Mn |
| Sep 30, 2023 | -37.23 Mn |
| Jun 30, 2023 | -19.79 Mn |
| Jun 30, 2023 | -19.79 Mn |
| Mar 31, 2023 | 5.35 Mn |
| Mar 31, 2023 | 5.35 Mn |
| Dec 31, 2022 | 11.52 Mn |
| Dec 31, 2022 | 11.52 Mn |
| Sep 30, 2022 | 46.88 Mn |
| Sep 30, 2022 | 46.88 Mn |
| Jun 30, 2022 | 159.12 Mn |
| Jun 30, 2022 | 159.12 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Dec 31, 2021 | -40.79 Mn |
| Dec 31, 2021 | -40.79 Mn |
| Sep 30, 2021 | -29.79 Mn |
| Sep 30, 2021 | -29.79 Mn |
| Jun 30, 2021 | -22.10 Mn |
| Jun 30, 2021 | -22.10 Mn |
| Mar 31, 2021 | -8.87 Mn |
| Mar 31, 2021 | -8.87 Mn |
| Dec 31, 2020 | -27.16 Mn |
| Dec 31, 2020 | -27.16 Mn |
| Sep 30, 2020 | -35.67 Mn |
| Sep 30, 2020 | -35.67 Mn |
| Jun 30, 2020 | 8.03 Mn |
| Jun 30, 2020 | 8.03 Mn |
| Mar 31, 2020 | 2.74 Mn |
| Mar 31, 2020 | 2.74 Mn |
| Dec 31, 2019 | -36.97 Mn |
| Dec 31, 2019 | -36.97 Mn |
| Sep 30, 2019 | -23.42 Mn |
| Sep 30, 2019 | -23.42 Mn |
| Jun 30, 2019 | -17.68 Mn |
| Jun 30, 2019 | -17.68 Mn |
| Mar 31, 2019 | 378.95 Mn |
| Mar 31, 2019 | 378.95 Mn |
| Dec 31, 2018 | -31.65 Mn |
| Dec 31, 2018 | -31.65 Mn |
| Sep 30, 2018 | 6.46 Mn |
| Sep 30, 2018 | 6.46 Mn |
| Jun 30, 2018 | -13.78 Mn |
| Jun 30, 2018 | -13.78 Mn |
| Mar 31, 2018 | -33.30 Mn |
| Mar 31, 2018 | -33.30 Mn |
| Dec 31, 2017 | -27.71 Mn |
| Dec 31, 2017 | -27.71 Mn |
| Sep 30, 2017 | 6.56 Mn |
| Sep 30, 2017 | 6.56 Mn |
| Jun 30, 2017 | -7.47 Mn |
| Jun 30, 2017 | -7.47 Mn |
| Mar 31, 2017 | -6.27 Mn |
| Mar 31, 2017 | -6.27 Mn |
| Dec 31, 2016 | -7.33 Mn |
| Dec 31, 2016 | -7.33 Mn |
| Sep 30, 2016 | -23.92 Mn |
| Sep 30, 2016 | -23.92 Mn |
| Jun 30, 2016 | -8.65 Mn |
| Jun 30, 2016 | -8.65 Mn |
| Mar 31, 2016 | 222.44 Mn |
| Mar 31, 2016 | 222.44 Mn |
| Dec 31, 2015 | 2.63 Mn |
| Dec 31, 2015 | 2.63 Mn |
| Sep 30, 2015 | -4.19 Mn |
| Sep 30, 2015 | -4.19 Mn |
| Jun 30, 2015 | -6.43 Mn |
| Jun 30, 2015 | -6.43 Mn |
| Mar 31, 2015 | -4.63 Mn |
| Mar 31, 2015 | -4.63 Mn |
| Dec 31, 2014 | -13.78 Mn |
| Dec 31, 2014 | -13.78 Mn |
| Sep 30, 2014 | -1.34 Mn |
| Sep 30, 2014 | -1.34 Mn |
| Jun 30, 2014 | -57,000.00 |
| Jun 30, 2014 | -57,000.00 |
| Mar 31, 2014 | -11.21 Mn |
| Mar 31, 2014 | -11.21 Mn |
| Dec 31, 2013 | -17.53 Mn |
| Dec 31, 2013 | -17.53 Mn |
| Sep 30, 2013 | -14.58 Mn |
| Sep 30, 2013 | -14.58 Mn |
| Jun 30, 2013 | -6.82 Mn |
| Jun 30, 2013 | -6.82 Mn |
| Mar 31, 2013 | 7.63 Mn |
| Mar 31, 2013 | 7.63 Mn |
| Dec 31, 2012 | -20.94 Mn |
| Dec 31, 2012 | -20.94 Mn |
| Sep 30, 2012 | -633,000.00 |
| Sep 30, 2012 | -633,000.00 |
| Jun 30, 2012 | -22.89 Mn |
| Jun 30, 2012 | -22.89 Mn |
| Mar 31, 2012 | 55.82 Mn |
| Mar 31, 2012 | 55.82 Mn |
| Dec 31, 2011 | -30.84 Mn |
| Dec 31, 2011 | -30.84 Mn |
| Sep 30, 2011 | -15.10 Mn |
| Sep 30, 2011 | -15.10 Mn |
| Jun 30, 2011 | -9.05 Mn |
| Jun 30, 2011 | -9.05 Mn |
| Mar 31, 2011 | -11.71 Mn |
| Mar 31, 2011 | -11.71 Mn |
| Dec 31, 2010 | -22.65 Mn |
| Dec 31, 2010 | -22.65 Mn |
| Sep 30, 2010 | 806,000.00 |
| Sep 30, 2010 | 806,000.00 |